ES vs LCTX · P/E 28, rev $11.90B vs rev $9.5M
Eversource Energy (ES) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
Eversource Energy (ES) is a utilities - regulated electric company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported ES revenue for 2024-12-31 was $11.90B. Net income was $819.2M. Revenue was down 0.1% from 2023-12-31 to 2024-12-31. ES currently screens at market cap $23.72B and trailing P/E 28.3.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
ES currently screens at market cap $23.72B and trailing P/E 28.3. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the ES and LCTX stock pages for the full models.
Not investment advice.